MHRA safety review of medicines containing pseudoephedrine

MHRA safety review of medicines containing pseudoephedrine Pseudoephedrine is used for the symptomatic relief of coughs, colds and allergies. Pseudoephedrine has been used in the UK for decades in millions and millions of people.

We are reviewing the available evidence relating to the very rare risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) associated with pseudoephedrine-containing medicines. PRES and RCVS are rare, reversible conditions, and most patients fully recover with appropriate treatment. Medicines and Healthcare products Regulatory Agency

See also:

• PRAC starts safety review of pseudoephedrine-containing medicines European Medicines Agency
• Nasal decongestant safety review due to rare brain risk BBC News
• The deadly conditions behind Sudafed safety review which may see flu remedies pulled from shelves The Daily Mail
• Are THESE what spooked health chiefs into a safety review of Sudafed? The Daily Mail
• Regulator reviewing cold and flu decongestants containing pseudoephedrine over rare brain risk ITV News
• MHRA to review evidence of harm linked to pseudoephedrine-containing medicines The Pharmaceutical Journal